ILDong: Ildong set to push releasing Covid-19 treatment Xocova to the end

Ildong Pharmaceutical has applied for a domestic permit for its Covid-19 treatment, Xocova (ensitrelvir fumaric acid), S-217622 in development name, drawing the industry's attention.In a public filing on Tuesday, Ildong said it has applied for the permit of Xocova 125 mg to the Ministry of Food and